[go: up one dir, main page]

WO2004095942A3 - Caffeinated tablet - Google Patents

Caffeinated tablet Download PDF

Info

Publication number
WO2004095942A3
WO2004095942A3 PCT/DE2004/000843 DE2004000843W WO2004095942A3 WO 2004095942 A3 WO2004095942 A3 WO 2004095942A3 DE 2004000843 W DE2004000843 W DE 2004000843W WO 2004095942 A3 WO2004095942 A3 WO 2004095942A3
Authority
WO
WIPO (PCT)
Prior art keywords
caffeinated
tablet
flavor
tablets
isomalt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2004/000843
Other languages
German (de)
French (fr)
Other versions
WO2004095942A2 (en
Inventor
Klaus Eichler
Wolfgang Kempe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipc Prozess Center & Co GmbH
Ipc Prozess Ct & Co GmbH
Original Assignee
Ipc Prozess Center & Co GmbH
Ipc Prozess Ct & Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10339864A external-priority patent/DE10339864A1/en
Application filed by Ipc Prozess Center & Co GmbH, Ipc Prozess Ct & Co GmbH filed Critical Ipc Prozess Center & Co GmbH
Publication of WO2004095942A2 publication Critical patent/WO2004095942A2/en
Publication of WO2004095942A3 publication Critical patent/WO2004095942A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A23L2/395—Dry compositions in a particular shape or form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/40—Effervescence-generating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to caffeinated tablets that can be administered orally, that are characterized by an improved taste and that are at least substantially devoid of undesired harmful effects. The caffeinated tablets according to the invention contain, in addition to pulverized caffeine, isomalt and xylitol in approximately equal percentages and constituting the major portion, a flavor or a flavor mixture and a binder.
PCT/DE2004/000843 2003-04-30 2004-04-16 Caffeinated tablet Ceased WO2004095942A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10320049 2003-04-30
DE10320049.5 2003-04-30
DE10339864.3 2003-08-26
DE10339864A DE10339864A1 (en) 2003-04-30 2003-08-26 Caffeine-containing tablet

Publications (2)

Publication Number Publication Date
WO2004095942A2 WO2004095942A2 (en) 2004-11-11
WO2004095942A3 true WO2004095942A3 (en) 2005-01-06

Family

ID=33420008

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2004/000843 Ceased WO2004095942A2 (en) 2003-04-30 2004-04-16 Caffeinated tablet

Country Status (1)

Country Link
WO (1) WO2004095942A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1027807C1 (en) * 2004-12-17 2006-06-20 4Sight Innovation Bv Device for enriching a beverage with additives, and packaging for such a device.
CN105412041A (en) * 2012-08-02 2016-03-23 佳格食品股份有限公司 Effervescent tablet with enhanced refreshing effect

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165511A (en) * 1996-04-22 2000-12-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Polyol composition
DE19943491A1 (en) * 1999-09-10 2001-03-15 Suedzucker Ag Improved compressions
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6444241B1 (en) * 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
WO2002078459A1 (en) * 2001-03-29 2002-10-10 Societe Des Produits Nestles S.A. Chewing gum-containing tablet

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165511A (en) * 1996-04-22 2000-12-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Polyol composition
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
DE19943491A1 (en) * 1999-09-10 2001-03-15 Suedzucker Ag Improved compressions
US6444241B1 (en) * 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
WO2002078459A1 (en) * 2001-03-29 2002-10-10 Societe Des Produits Nestles S.A. Chewing gum-containing tablet

Also Published As

Publication number Publication date
WO2004095942A2 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
WO2006128057A3 (en) Oral dosage forms comprising progesterone and methods of making and using the same
WO2000067739A3 (en) Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
WO2009006095A3 (en) Dual portion lozenge dosage form
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
WO2008070795A3 (en) Combination therapy using low-dose doxepin for the improvement of sleep
CA2574567A1 (en) Flavoring a cigarette by using a flavored filter plug wrap
AP2012006231A0 (en) Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
AU2003244632A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
WO2010066749A3 (en) Ulipristal acetate tablets
AU2003244649A1 (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
WO2006034463A3 (en) Herbal supplement to support weight loss
EP1346732A3 (en) Dosage forms for hygroscopic active ingredients
WO2004078105A3 (en) Fondaparinux sodium composition of high purity, method for production of said composition and pharmaceutical compositions containing the same as active ingredient
WO2001034125A3 (en) Therapeutic use and formulation of (-)-tramadol
WO2007059953A8 (en) Formulation comprising a polyphenol-containing composition and isomaltulose
ATE442052T1 (en) COFFEE COMPOSITION AND METHOD FOR PRODUCING IT
WO2007038506A3 (en) Method for the treatment of cachexia
WO2003035080A3 (en) A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
WO2002011724A3 (en) Neuroprotective 2-pyridinamine compositions and related methods
WO2002012198A3 (en) 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
WO2005070183A3 (en) Ice cream and ice cream formulations containing maltitol
WO2004095942A3 (en) Caffeinated tablet
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase